Anikó Göblyös

Title: Anikó Göblyös: Innovator in A3 Adenosine Receptor Modulation

Introduction

Anikó Göblyös is a notable inventor based in Ujszasz, Hungary. He has made significant contributions to the field of pharmacology, particularly in the modulation of A3 adenosine receptors. His innovative work has led to the development of a patent that holds promise for therapeutic applications.

Latest Patents

Anikó Göblyös holds a patent for A3 adenosine receptor allosteric modulators. The claimed subject matter relates to allosteric modulation of the A3 adenosine receptor (AAR) and provides for the use of an A3 adenosine receptor modulator (ARM) for the preparation of pharmaceutical compositions. These compositions are designed to modulate AAR activity in a subject. The ARM described in the patent includes 1H-Imidazo-[4,5-c]quinolin-4-amine derivatives, which are crucial for the therapeutic methods involving the administration of an effective amount of an ARM.

Career Highlights

Throughout his career, Anikó Göblyös has worked with prestigious institutions, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Universiteit Leiden. His experience in these organizations has enriched his expertise in pharmacological research and development.

Collaborations

Anikó has collaborated with notable colleagues such as Johannes Brussee and Adriaan Pieter Ijzerman. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Anikó Göblyös is a distinguished inventor whose work in A3 adenosine receptor modulation has the potential to impact pharmaceutical development significantly. His contributions to the field exemplify the importance of innovation in medical science.